Showing results (221-230 of 793) with videos related to

Sort By:
Pageof 80
Hematology (Amsterdam, Netherlands)|September 3, 2021
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myelomaChor Sang Chim, Shaji Kumar, Vincent Kai Chung Wong, et al.
Expert Review of Hematology|January 12, 2017
Deacetylase inhibitors: an advance in myeloma therapy?Jacob P Laubach, Jesus F San-Miguel, Vania Hungria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 SignalingJie Li, Chaoyun Pan, Austin C Boese, et al.
Expert Opinion on Pharmacotherapy|November 14, 2018
Ixazomib for the treatment of multiple myelomaPaul G Richardson, Sonja Zweegman, Elizabeth K O'Donnell, et al.
Blood|September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomesEbenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Facilitating T-cell immune reconstitution after haploidentical transplantation in adultsEdmund K Waller, Cynthia R Giver, Hilary Rosenthal, et al.
Pageof 80